Misako Nagasaka

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    AstraZeneca
    Date added:
    11/09/2022
    Date updated:
    03/13/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Daiichi Sankyo
    Date added:
    11/09/2022
    Date updated:
    03/13/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Novartis
    Date added:
    11/09/2022
    Date updated:
    03/13/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    EMD Serono
    Date added:
    11/09/2022
    Date updated:
    03/13/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Pfizer
    Date added:
    11/09/2022
    Date updated:
    03/13/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Lilly
    Date added:
    11/09/2022
    Date updated:
    03/13/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Genentech
    Date added:
    11/09/2022
    Date updated:
    03/13/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Mirati
    Date added:
    11/09/2022
    Date updated:
    03/13/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Caris Life Sciences
    Date added:
    11/09/2022
    Date updated:
    03/13/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Takeda
    Date added:
    11/09/2022
    Date updated:
    03/13/2024

Pages

Return to San Diego Multidisciplinary Thoracic Oncology Symposium: Patient-centered approach to improve outcomes